1. Volume 76, Issue 5, Pages 567-575 (September 2009)
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients 
Christiane Drechsler, Vera Krane, Karl Winkler, Friedo W. Dekker, Christoph Wanner 
Kidney International 
Volume 76, Issue 5, Pages (September 2009)
DOI: /ki
Copyright © 2009 International Society of Nephrology Terms and Conditions

2. Figure 1
Correlations of adiponectin with BMI NT-Pro BNP and CRP. (a–c) Correlations of adiponectin (log transformed) with (a) body mass index, (b) NT-pro-BNP (log transformed), and (c) C-reactive protein (log transformed).
Kidney International  , DOI: ( /ki )
Copyright © 2009 International Society of Nephrology Terms and Conditions

3. Figure 2
Changes in adiponectin and adverse outcomes. (a–c) Kaplan–Meier curves for the time to (a) sudden death, (b) myocardial infarction, and (c) all-cause mortality by tertiles of the change in adiponectin from baseline. Tertile 1: patients with a decrease in adiponectin greater than or equal to 12.8% (n=400), Tertile 2: patients with stable adiponectin levels (change in adiponectin between and +12.3%; n=402), Tertile 3: patients with an increase in adiponectin greater than 12.3% (n=400).
Kidney International  , DOI: ( /ki )
Copyright © 2009 International Society of Nephrology Terms and Conditions